Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133692) titled 'Development and external validation of a prognostic prediction model for liver cancer based on the SEER and TCGA databases' on Sept. 30.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Central Hospital of Dalian University of Technology
Dalian Municipal Central Hospital
Condition:
Hepatocellular carcinoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-30
Target Sample Size: Observation group:300;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=345908
Published by HT Digital Content Services w...